Back to Search Start Over

Acute teriflunomide overdose with relatively mild symptoms: A case report.

Authors :
Mian P
van Haaften WT
Assink M
van Drie-Pierik RJHM
Source :
Journal of clinical pharmacy and therapeutics [J Clin Pharm Ther] 2021 Dec; Vol. 46 (6), pp. 1784-1786. Date of Electronic Publication: 2021 Jan 09.
Publication Year :
2021

Abstract

What Is Know and Objective: Teriflunomide is indicated for the treatment of adult patients with relapsing-remitting multiple sclerosis.<br />Case Summary: We present a rare intoxication with a high dose (672 mg) of teriflunomide. According to its product label, the only known treatment is the administration of colestyramine and activated carbon (charcoal). No serious adverse events occurred during the time the patient was admitted (<24 h). No long-term overdose-related symptoms or complaints were reported.<br />What Is New and Conclusion: The fact that after the acute overdose both adverse events and laboratory parameters were acceptable, prescribing colestyramine and activated carbon, as well as monitoring of laboratory parameters such as full blood count, liver and kidney values and QTc, seems sufficient during the early stage (<24 h after intake) of teriflunomide overdose.<br /> (© 2021 John Wiley & Sons Ltd.)

Details

Language :
English
ISSN :
1365-2710
Volume :
46
Issue :
6
Database :
MEDLINE
Journal :
Journal of clinical pharmacy and therapeutics
Publication Type :
Report
Accession number :
33421160
Full Text :
https://doi.org/10.1111/jcpt.13360